At the protein level, OAS1 risk variant has been found to be linked to decreased enzymatic activity in human peripheral blood mononuclear cells and viral clearance, which supports a potential role for defective viral infection resistance due to altered interferon response as a genetic pathophysiological basis of this complex autoimmune disease. The gene discussed is OAS1; the disease is autoimmune disease.